Life Biosciences tests ER-100, a gene therapy that aims to restore vision by rejuvenating damaged retinal neurons.
“The last thing a presbyopic patient wants is to abandon their reading glasses and walk around with cosmetically red eyes,” Donnenfeld noted. “In BRIO-II, the rate of reported adverse events of ocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results